Access cutting-edge liver disease treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access liver disease specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver disease treatment provided free
This Phase 2a clinical trial is a dose escalation study of the safety, tolerability, and efficacy of hepatocyte transplantation into lymph nodes via endoscopic ultrasound among subjects with end-stage liver disease.
Sponsor: LyGenesis, Inc.
Check if you qualify for this liver disease clinical trial in Boston, MA
If you're searching for liver disease treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.